This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Talk:Withania somnifera (botany): Difference between revisions
>Unity Proofreading, grammatics. |
>Catharsis Withanolide series additions |
||
| Line 9: | Line 9: | ||
==Chemistry== | ==Chemistry== | ||
{{Chemistry}} | {{Chemistry}} | ||
Withanolides are present in all plants in the Solanaceae family of plants, of which Withania Somnifera(Ashwagandha) is the highest in concentrations. These Withanolides are believed to be the prime component of Ashwagandha's psychoactive profile.[ | Withanolides are present in all plants in the Solanaceae family of plants, of which Withania Somnifera(Ashwagandha) is the highest in concentrations. These Withanolides are believed to be the prime component of Ashwagandha's psychoactive profile.<ref>A standardized root extract of Withania somnifera and its major constituent withanolide-A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c mice. | https://www.ncbi.nlm.nih.gov/pubmed/17336338</ref>There has been reported to be high variability in the amount of active withanolides in common nutritional supplements, which may be due to lack of standardization of root powder.[[Withanolide_series.png|thumb|right|upright|200px|Chemical structure of Withanolides found in Ashwagandha]] | ||
==Pharmacology== | ==Pharmacology== | ||
Theanine is structurally similar to the excitatory [[neurotransmitter]] [[glutamate]], and in accordance, binds to glutamate [[receptor]]s, though with much lower affinity in comparison. Specifically, it binds to ionotropic glutamate receptors including the [[AMPA]] and [[kainate]] receptors and, to a lesser extent, the [[NMDA]] receptor.<ref>The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/17182482</ref><ref>Inhibition by theanine of binding of [3H]AMPA, [3H]kainate, and [3H]MDL 105,519 to glutamate receptors (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/12596867</ref><ref>Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/21477654</ref><ref>Neuroprotective effects of the green tea components theanine and catechins (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/12499631</ref> It acts as an [[antagonist]] of the former two sites<ref>Neuroprotective effects of the green tea components theanine and catechins (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/12499631</ref> and as an [[agonist]] of the latter site.<ref>Behavioral and molecular evidence for psychotropic effects in L-theanine (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/21861094</ref> In addition, it inhibits glutamine transporters and glutamate transporters, and thus acts as [[reuptake inhibitor]] of glutamine and glutamate.<ref>Neuroprotective effects of the green tea components theanine and catechins (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/12499631</ref><ref>Inhibition of glutamate transporter by theanine enhances the therapeutic efficacy of doxorubicin (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/11325559</ref><ref>Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/14643924</ref> | Theanine is structurally similar to the excitatory [[neurotransmitter]] [[glutamate]], and in accordance, binds to glutamate [[receptor]]s, though with much lower affinity in comparison. Specifically, it binds to ionotropic glutamate receptors including the [[AMPA]] and [[kainate]] receptors and, to a lesser extent, the [[NMDA]] receptor.<ref>The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/17182482</ref><ref>Inhibition by theanine of binding of [3H]AMPA, [3H]kainate, and [3H]MDL 105,519 to glutamate receptors (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/12596867</ref><ref>Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/21477654</ref><ref>Neuroprotective effects of the green tea components theanine and catechins (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/12499631</ref> It acts as an [[antagonist]] of the former two sites<ref>Neuroprotective effects of the green tea components theanine and catechins (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/12499631</ref> and as an [[agonist]] of the latter site.<ref>Behavioral and molecular evidence for psychotropic effects in L-theanine (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/21861094</ref> In addition, it inhibits glutamine transporters and glutamate transporters, and thus acts as [[reuptake inhibitor]] of glutamine and glutamate.<ref>Neuroprotective effects of the green tea components theanine and catechins (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/12499631</ref><ref>Inhibition of glutamate transporter by theanine enhances the therapeutic efficacy of doxorubicin (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/11325559</ref><ref>Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/14643924</ref> | ||